Zdrowie i gospodarka · 3/6/1997
Chlorofluorocarbon Propellants in Self-Pressurized Containers; Determinations That Uses Are No Longer Essential; Request for Comments
The Food and Drug Administration (FDA) is seeking public comment on the policy it is considering for adoption on making and implementing determinations that uses of chlorofluorocarbons (CFC's) currently designated essential will no longer be deemed essential under the Clean Air Act due to the availability of safe and effective medical product technology that does not use CFC's. Essential-use products are exempt from FDA's ban on the use of CFC propellants in FDA-regulated products and the Environmental Protection Agency's (EPA's) ban on the use of CFC's in pressurized dispensers. The agency is taking this action because it is responsible for determining which products containing CFC's or other ozone-depleting substances are an essential use under the Clean Air Act. FDA is soliciting comments on this policy to assist the agency in striking an appropriate balance that will best protect the public health, both by ensuring the availability of an adequate number of treatment alternatives and by curtailing the release of ozone-depleting substances.